Anson Funds Management LP - 30 Jun 2025 SCHEDULE 13G/A Report for Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA)

Filing Manager: Anson Funds Management LP
Reporting Manager: Anson Funds Management LP
Security: Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol: HEPA
Shares outstanding: 11,764,939 shares
Disclosed Ownership: 576,482 shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 21:41:01 UTC
Date of event: 30 Jun 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Key filing fact

Anson Funds Management LP disclosed 4.9% ownership in Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA) on 30 Jun 2025.

Key facts

Anson Funds Management LP filed SCHEDULE 13G/A for Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA).
Disclosed ownership: 4.9%.
Date of event: 30 Jun 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Anson Funds Management LP	4.9%	576,482	576,482	/s/ Tony Moore	Tony Moore, Manager
Anson Management GP LLC	4.9%	576,482	576,482	/s/ Tony Moore	Tony Moore, Manager
Tony Moore	4.9%	576,482	576,482	/s/ Tony Moore	Tony Moore, Manager
Anson Advisors Inc.	4.9%	576,482	576,482	/s/ Amin Nathoo	Amin Nathoo, Director
Amin Nathoo	4.9%	576,482	576,482	/s/ Amin Nathoo	Amin Nathoo, Director
Moez Kassam	4.9%	576,482	576,482	/s/ Moez Kassam	Moez Kassam, Director

CIK / CUSIP context first

Broader feeds